Tokyo Bay Urayasu Ichikawa Medical Center | Clinical Service Co., Ltd.
Status
Conditions
Treatments
About
An exploratory evaluation of the efficacy and safety of CLZ-BM3D for the treatment of symptomatic peripheral occlusive arterial disease of the superficial femoral artery or proximal popliteal artery
Full description
This Study demonstrate an exploratory evaluation of the efficacy and safety of CLZ-BM3D for the treatment of symptomatic peripheral occlusive arterial disease of the superficial femoral artery or proximal popliteal artery
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
However, a history of balloon dilatoplasty with POBA is acceptable if it was performed earlier than 12 months prior to enrollment.
However, if the patient has another stenotic lesion in the iliac artery other than the target lesion, treatment of the iliac artery lesion (POBA and stenting) is allowed at the time of the study procedure.
Primary purpose
Allocation
Interventional model
Masking
24 participants in 1 patient group
Loading...
Central trial contact
Mikiko Haraguchi
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal